Table 1.
Patient Characteristics (N=112)
| Patient Characteristics | n (%) |
|---|---|
| Age at diagnosis, mean (SD) | 59.7 (10.0) |
| Region of residencea | |
| Northeast | 28 (25) |
| Southeast | 77 (69) |
| South | 7 (6) |
| Stage | |
| I–II | 19 (17) |
| III–IV | 92 (83) |
| Unknown | 1 |
| Neoadjuvant chemotherapy | |
| Yes | 15 (16) |
| No | 79 (84) |
| Unknown | 18 |
| Adjuvant chemotherapy | |
| Yes | 81 (93) |
| No | 6 (7) |
| Unknown | 25 |
| Residual diseaseb | |
| Optimal debulking | 57 (61) |
| Suboptimal debulking | 36 (39) |
| Unknown | 19 |
| Survival duration (years), mean (SD) | 2.9 (1.5) |
| Vital Status | |
| Deceased | 47 (42) |
| Alive | 65 (58) |
SD: standard deviation.
a
The Northeast region includes Michigan, Illinois, New Jersey and Ohio. The Southeast region includes Georgia, Tennessee, North Carolina and South Carolina. The South region includes Alabama, Texas and Louisiana.
b
Residual disease is defined as optimal if <1cm tumor diameter after cytoreductive surgery or a CA-125 <35 after the last cycle of the first round of adjuvant chemotherapy.